Nuvectis Pharma Attracts Significant Insider Investment Amid Promising Oncology Pipeline
Nuvectis Pharma (NASDAQ: NVCT) has become a focal point for savvy investors, notably Charles Mosseri-Marlio, a seasoned biotech investor and former pharmaceutical executive, who has significantly increased his stake in...